177 related articles for article (PubMed ID: 37446633)
1. Oxoglaucine Suppresses Hepatic Fibrosis by Inhibiting TGFβ-Induced Smad2 Phosphorylation and ROS Generation.
Azamov B; Lee KM; Hur J; Muradillaeva S; Shim WS; Lee C; Song P
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446633
[TBL] [Abstract][Full Text] [Related]
2. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
3. Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2/3 at linker regions in vivo and in vitro.
Wu C; Chen W; Ding H; Li D; Wen G; Zhang C; Lu W; Chen M; Yang Y
Life Sci; 2019 Dec; 239():116881. PubMed ID: 31678285
[TBL] [Abstract][Full Text] [Related]
4. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
[TBL] [Abstract][Full Text] [Related]
5. Miglustat, a glucosylceramide synthase inhibitor, mitigates liver fibrosis through TGF-β/Smad pathway suppression in hepatic stellate cells.
Iwanaga T; Chiba T; Nakamura M; Kaneko T; Ao J; Qiang N; Ma Y; Zhang J; Kogure T; Yumita S; Ishino T; Ogawa K; Kan M; Nakagawa M; Fujiwara K; Fujita N; Sakuma T; Kanzaki H; Koroki K; Kusakabe Y; Inoue M; Kobayashi K; Kanogawa N; Kiyono S; Kondo T; Nakagawa R; Ogasawara S; Nakamoto S; Muroyama R; Kato J; Kanda T; Maruyama H; Mimura N; Honda T; Murayama T; Nakamura H; Kato N
Biochem Biophys Res Commun; 2023 Jan; 642():192-200. PubMed ID: 36586187
[TBL] [Abstract][Full Text] [Related]
6. Limonin relieves TGF-β-induced hepatocyte EMT and hepatic stellate cell activation in vitro and CCl
Shu G; Dai C; Yusuf A; Sun H; Deng X
J Nutr Biochem; 2022 Sep; 107():109039. PubMed ID: 35533902
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 Scaffolding Domain Peptides Alleviate Liver Fibrosis by Inhibiting TGF-β1/Smad Signaling in Mice.
Lu J; Zhang J; Wang Y; Sun Q
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891777
[TBL] [Abstract][Full Text] [Related]
8. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
9. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
[TBL] [Abstract][Full Text] [Related]
10. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling.
Chen C; Chen J; Wang Y; Fang L; Guo C; Sang T; Peng H; Zhao Q; Chen S; Lin X; Wang X
Phytomedicine; 2023 Feb; 110():154626. PubMed ID: 36603342
[TBL] [Abstract][Full Text] [Related]
11. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
Tang LX; He RH; Yang G; Tan JJ; Zhou L; Meng XM; Huang XR; Lan HY
PLoS One; 2012; 7(2):e31350. PubMed ID: 22363627
[TBL] [Abstract][Full Text] [Related]
12. Adipose-Derived Stem Cells (ADSCs) Supplemented with Hepatocyte Growth Factor (HGF) Attenuate Hepatic Stellate Cell Activation and Liver Fibrosis by Inhibiting the TGF-β/Smad Signaling Pathway in Chemical-Induced Liver Fibrosis Associated with Diabetes.
Gharbia S; Nazarie SR; Dinescu S; Balta C; Herman H; Peteu VE; Gherghiceanu M; Hermenean A; Costache M
Cells; 2022 Oct; 11(21):. PubMed ID: 36359733
[TBL] [Abstract][Full Text] [Related]
13. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways.
Park JH; Park B; Park KK
Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28406452
[TBL] [Abstract][Full Text] [Related]
15. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
Gong Y; Yang Y
Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
[TBL] [Abstract][Full Text] [Related]
16. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
[TBL] [Abstract][Full Text] [Related]
17. Glaucocalyxin A Attenuates the Activation of Hepatic Stellate Cells Through the TGF-β1/Smad Signaling Pathway.
Dong Z; Gao Q; Guo H
DNA Cell Biol; 2018 Mar; 37(3):227-232. PubMed ID: 29327938
[TBL] [Abstract][Full Text] [Related]
18. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect.
Xu L; Zheng N; He Q; Li R; Zhang K; Liang T
Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441
[TBL] [Abstract][Full Text] [Related]
19. Amygdalin Ameliorates Liver Fibrosis through Inhibiting Activation of TGF-β/Smad Signaling.
Xiao Z; Ji Q; Fu YD; Gao SQ; Hu YH; Liu W; Chen GF; Mu YP; Chen JM; Liu P
Chin J Integr Med; 2023 Apr; 29(4):316-324. PubMed ID: 34816365
[TBL] [Abstract][Full Text] [Related]
20. Trimetazidine inhibits liver fibrosis and hepatic stellate cell proliferation and blocks transforming growth factor-β (TGFβ)/Smad signaling
Ding W; Zhou D; Zhang S; Qian J; Yang L; Tang L
Bioengineered; 2022 Mar; 13(3):7147-7156. PubMed ID: 35249457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]